Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Company Profile and bullboard matches:

V.PLAN , PGR , RXMD , PGSC
Sort by: Date|Relevance

Biotech's 'Multiple Sclerosis Therapy Shows Improvement in Disability'

Atara Biotherapeutics' clinical trial design and results are reviewed in a ROTH Capital Partners report. In a May 26 research note, ROTH Capital Partners analyst Tony Butler purported that Atara Biotherapeutics Inc.'s (ATRA:NASDAQ) "updated data from the Phase 1 ...
Streetwise Reports | May 28, 2020 |

Prospecting the Americas While Generating Real Shareholder Value

It’s not often a junior mining explorer is as geographically and minerally diversified in its property holdings as Alianza Minerals Ltd. (ANZ) ( TSX-V.ANZ , OTC:TARSF , Forum ). Then again, few mining companies are as progressive thinking in developing t...
Dave Jackson | May 29, 2020 |

Intercept Pharma Shares Rise on FDA Acceptance of NDA for Liver Fibrosis Treatment

Shares of Intercept Pharmaceuticals rose today after the company reported that the U.S. Food and Drug Administration accepted its NDA for obeticholic acid (OCA) for the treatment of liver fibrosis due to NASH and granted priority review status. This morning biopharmac...
Streetwise Reports | November 27, 2019 |

What is DehydraTECH and how is it revolutionizing solutions in cannabis and alcohol-free beverages?

Hill ( TSXV:HILL ) is a progressive innovation company that utilizes new technologies to provide innovative cannabis solutions and non-alcoholic beverage products globally. It is pioneering the space where craft consumer products meet bioscience by leveraging its deep CP...
Research | June 1, 2023 |

Revenues surge 5x with the continued deployment and expansion of DehydraTECH in US markets

See: Hill Incorporated Releases FY2023 Q3 Financial Results . Hill ( TSXV:HILL ) is a progressive innovation company that utilizes new technologies to provide innovative cannabis solutions and non-alcoholic beverage products globally. It is pioneering the spa...
Research | June 5, 2023 |

Calculate the Trading Strategies' Profitability like a Pro

Investors venture into cryptocurrency trading to gain profits. They employ customized trading strategies, portfolio management strategies, and progressive investment decisions throughout their trade. Due to the progressive nature of trading, tracking one&CloseCurlyQuote...
Julia Beyers | September 5, 2019 |

Has the Equities Waterfall Event Started Or A Buying Opportunity?

Over the past 5+ days, a very clear change in market direction has taken place in the US and global markets. Prior to this, the US markets were reacting to Q4 earnings data and minimizing the potential global pandemic of the Coronavirus. The continued “rally to the peak&Clos...
Chris Vermeulen | February 24, 2020 |

Applied Genetic Tech's Shares Double on 6-Month X-Linked RP Study Results

Shares of Applied Genetic Technologies skyrocketed to a new 52-week high price after the company reported positive six-month data from its ongoing Phase 1/2 clinical study for treatment in X-Linked Retinitis Pigmentosa. The firm stated that the trial data suggests durable and ...
Streetwise Reports | January 10, 2020 |

Construction Pipeline Shows Undervalued Opportunity

This Vancouver Construction Company Continues to Trade Undervalued with a Long List of Projects in the Pipeline. A Vancouver-based general contracting company, with a list of international jobs in the pipeline, is trading for just eight cents apiece right now. From ea...
Fraser Palamara | March 10, 2021 |

Meet Mining’s ‘Prospect Generator’ that’s Generating Real Buzz

It is rare in today’s metals & mining markets to find a junior explorer that is as geographically and minerally diversified in its property holdings as Alianza Minerals Ltd. (ANZ) ( TSX-V.ANZ , OTC:TARSF , Forum ). Then again, few mineral exploration com...
Dave Jackson | November 2, 2020 |
1 2 3 4 5 6